PI3K (Phosphoinositide 3-kinase) is a family of lipid kinases that catalyze the phosphorylation of phosphatidylinositol (PI) lipids on the 3-position of the inositol ring, generating phosphatidylinositol-3,4,5-trisphosphate (PIP3) from phosphatidylinositol-4,5-bisphosphate (PIP2). This lipid second messenger serves as a critical signaling hub that regulates cell survival, growth, metabolism, and trafficking in neurons[1].
The PI3K family comprises multiple classes with distinct functions:
In the brain, PI3K signaling plays essential roles in neuronal development, synaptic plasticity, and neuroprotection. Dysregulation of PI3K/Akt signaling is implicated in Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and other neurodegenerative conditions[2].
| Property | Value |
|---|---|
| Gene Symbol | PI3K (family), PIK3CA, PIK3CB, etc. |
| Protein | Phosphoinositide 3-kinase |
| Chromosomal Location | Various (multiple genes across classes) |
| NCBI Gene ID | Multiple (e.g., PIK3CA: 5290, PIK3CB: 5293) |
| Aliases | PI3K, Phosphatidylinositol 3-kinase, VPS34 |
| Associated Diseases | Alzheimer's, Parkinson's, Huntington's, ALS |
PI3Ks phosphorylate phosphatidylinositol (PI) and its derivatives:
Class I PI3Ks: Generate PIP3 from PIP2
Class II PI3Ks: Produce PI(3)P from PI
Class III PI3Ks (VPS34): Generate PI(3)P
Growth Factor → RTK → PI3K → PIP3 → Akt → mTOR/GSK3β → Cell Survival
↑
PTEN (negative regulator)
PI3K is regulated by:
In neurons, PI3K signaling regulates:
Synaptic plasticity: PI3K is required for long-term potentiation (LTP) and memory formation. Akt-mediated phosphorylation of GSK3β reduces tau phosphorylation, protecting synaptic function[4].
Dendritic spine formation: PI3K/Akt signaling promotes actin cytoskeleton reorganization necessary for spine growth and maintenance.
Neurotrophin signaling: BDNF and NGF signal through Trk receptors to activate PI3K/Akt, promoting neuronal survival and differentiation[5].
Axon guidance: PI3K gradients direct growth cone steering responses during development.
Glucose metabolism: PI3K/Akt regulates neuronal glucose uptake and metabolism, critical for energy-demanding synaptic activity[6].
Autophagy: PI3K class III (VPS34) initiates autophagosome formation, essential for clearing protein aggregates and damaged organelles[7].
Mitochondrial dynamics: PI3K/Akt regulates mitochondrial fission, fusion, and trafficking in neurons[8].
PI3K/Akt signaling is profoundly disrupted in AD, contributing to multiple pathological features:
Amyloid-beta toxicity:
Tau pathology:
Insulin resistance:
Synaptic failure:
Neuroinflammation:
PI3K/Akt signaling is neuroprotective for dopaminergic neurons in the substantia nigra:
PINK1/Parkin pathway:
Dopaminergic neuron survival:
Alpha-synuclein toxicity:
Neuroinflammation:
Akt/PKB:
mTORC1:
GSK3β:
Normal State:
Growth Factor → PI3K → Akt → GSK3β(inactive) → Normal tau → Neuroprotection
AD State:
Aβ → PI3K(inhibited) → Akt(inactive) → GSK3β(active) → Hyperphosphorylated tau → NFTs
PI3K activators: Small molecules that enhance PI3K activity
Akt activators: Direct Akt phosphorylation or allosteric activators
mTOR inhibitors: Rapamycin, rapamycin analogs
GSK3β inhibitors: Reduce tau pathology
PTEN inhibitors: Reduce PIP3 dephosphorylation
Combination therapies: Multi-target approaches
| Strategy | Development Stage | Notes |
|---|---|---|
| mTOR inhibitors (rapamycin) | Preclinical/Clinical | Autophagy induction |
| Akt activators | Preclinical | Neuroprotection |
| GSK3β inhibitors | Clinical trials | Tau targeting |
| PI3K isoform-selective | Preclinical | Reduced side effects |
| Protein/Gene | Interaction Type | Pathway | Role in Neurodegeneration |
|---|---|---|---|
| PTEN | Opposing enzyme | Signaling | Negative regulator, overactive in AD |
| Akt/PKB | Downstream kinase | Survival | Neuroprotective, reduced in AD |
| mTOR | Downstream kinase | Growth/synthesis | Overactive, promotes tau pathology |
| GSK3-beta | Downstream substrate | Tau phosphorylation | Activated when PI3K impaired |
| Ras | Activator | Signaling | GTPase upstream activator |
| p85 (PIK3R1) | Regulatory subunit | Localization | Adapter for membrane recruitment |
| BDNF | Activator via TrkB | Neurotrophin signaling | Neuroprotective |
| IRS-1 | Substrate | Insulin signaling | Dysregulated in AD brain |
| TSC1/TSC2 | Upstream regulator | mTOR signaling | Integrates PI3K/Akt and mTOR |
PTEN in neuronal development and neurodegeneration. 2024. ↩︎
Growth factor signaling through PI3K in neuroprotection. 2024. ↩︎
PI3K/Akt/mTOR autophagy regulation in neurodegeneration. 2024. ↩︎
PI3K/Akt in mitochondrial dynamics and neuronal survival. 2023. ↩︎
Insulin signaling disruption in Alzheimer's disease. 2024. ↩︎
PI3K signaling in neuroinflammation and neurodegeneration. 2023. ↩︎